K145 hydrochloride

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

K145 盐酸盐是一种选择性 sphk2 抑制剂，具有底物竞争性和口服活性，IC50 为 4.3 μM，Ki 为 6.4 μM。 K145盐酸盐可诱导细胞凋亡，具有较强的抗肿瘤活性。

K145 hydrochloride is a selective sphk2 inhibitor with substrate competitiveness and oral activity, with IC50 of 4.3 μM and Ki of 6.4 μM. K145 hydrochloride can induce apoptosis and has strong antitumor activity.(In Vitro):K145 hydrochloride inhibited the activity of SphK2 in a dose-dependent manner with an IC50 of 4.30 μM. The Lineweaver-Burk analysis revealed a Ki of 6.4±0.7 μM for SphK2 and indicated that K145 hydrochloride is a substrate competitive inhibitor (with sphingosine). K145 hydrochloride accumulates in U937 cells, suppresses the S1P level, and inhibits SphK2. K145 hydrochloride also exhibited inhibitory effects on the growth of U937 cells as well as apoptotic effects in U937 cells, and that these effects may be through the inhibition of downstream ERK and Akt signaling pathways.(In Vivo):In BALB/c-nu mice injected with U937 cells, K145 hydrochloride (50 mg/kg; oral gavage; for 15 days) treatment significantly inhibited the growth of U937 tumors at 50 mg/kg dose and no apparent toxicity was observed.

K145 (0-10 μM; 24-72 hours; U937 cells) treatment significantly inhibits the growth of U937 cells in a concentration-dependent manner.K145 (10 μM; 24 hours; U937 cells) treatment significantly induces apoptosis in U937 cells.K145 (4-8 μM; 3 hours; U937 cells) treatment decreases the phosphorylation of ERK and Akt.Treatment with K145 (10 μM) causes a decrease of total cellular S1P without significant effects on ceramide levels. Cell Viability Assay Cell Line:U937 cells Concentration:0 μM, 4 μM, 6 μM, 8 μM, 10 μM Incubation Time:24 hours, 48 hours, 72 hours Result:Significantly inhibited the growth of U937 cells in a concentration-dependent manner.Apoptosis Analysis Cell Line:U937 cells Concentration:10 μM Incubation Time:24 hours Result:Significantly induced apoptosis in U937 cells.Western Blot Analysis Cell Line:U937 cells Concentration:4 μM, 8 μM Incubation Time:3 hours Result:Phosphorylated ERK and Akt were decreased.

K145 (50 mg/kg; oral gavage; daily; for 15 days; BALB/c-nu mice) treatment significantly inhibits the growth of U937 tumors in nude mice. Animal Model:BALB/c-nu mice injected with U937 cells Dosage:50 mg/kg Administration:Oral gavage; daily; for 15 days Result:Inhibited the growth of U937 tumors at 50 mg/kg dose and no apparent toxicity was observed.

——

Apoptosis

Apoptosis

Apoptosis

——

——

1449240-68-9

384.92

C18H25ClN2O3S

>98% (HPLC)

In Vitro:?H2O : 126.7 mg/mL (329.16 mM)

Cl.CCCCOc1ccc(CC\C=C2/SC(=O)N(CCN)C2=O)cc1

——

(-20℃)

With Ice Pack

≥ 2 years